Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine (CAREER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01380288
Recruitment Status : Completed
First Posted : June 27, 2011
Last Update Posted : February 5, 2018
Sponsor:
Collaborator:
Novartis Korea Ltd.
Information provided by (Responsible Party):
Kyungil Park, Dong-A University